Our study suggests that strategies to develop more effective pertussis vaccines that prevent nasal infection and asymptomatic transmission of B. pertussis need to consider the induction of IL-17-producing TRM cells that recruit neutrophils to control infection of the nasal mucosae. The gene discussed is IL17A; the disease is pertussis.